Blog

Blog

by Quanterix

Top 5 Reasons We Love Biomarkers…

by Kevin Hrusovsky

We recently sat down with oncologist Dr. Azra Raza of Columbia University to discuss her book, The First Cell, our fight to shift healthcare paradigms toward prevention and early detection, and how the Powering Precision Health (PPH) movement and Quanterix can help lead the battle cry for change. Interestingly, I was with Cleveland Clinic executives, healthcare executives, and state of Ohio government officials earlier in the week, and we had the exact same discussion and call to action.

BY KEVIN HRUSOVSKY, PRESIDENT, CHAIRMAN AND CEO QUANTERIX

Though the 2019 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference has passed, Quanterix is not slowing down and working hard to continue the

By Kevin Hrusovsky, President, Chairman and CEO Quanterix

February often makes us reflect upon our hearts. For some, it’s the trials and tribulations of love, with Valentine’s Day just recently passing us by. However, for many others, battles with the heart have much graver consequences, with heart disease remaining the leading cause of death worldwide.

By Kevin Hrusovsky, President, Chairman and CEO Quanterix

The 36th annual J.P Morgan Healthcare conference took over San Francisco earlier this month. With more than 10,000 attendees, representing more than 450 private and public companies, the event is the largest healthcare investment symposium in the industry. This year’s event was keynoted by leading industry executives, including Bill Gates. Bill inspired the attendees as he showcased some of the accomplishments that the Bill & Melinda Gates Foundation has achieved this year, including progress lowering child mortality rates and combating diseases that disproportionately affect people in developing and third world countries.